Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Melatonin is known for its protective effects against cardiovascular diseases.
• Myocardial infarction (MI) leads to significant cardiac dysfunction and adverse remodeling.
• Understanding melatonin's role in post-MI cardiac recovery is crucial.

Purpose of the Study:

• To investigate the effects of melatonin on cardiomyocyte autophagy, apoptosis, and mitochondrial injury following MI.
• To elucidate the underlying molecular mechanisms, particularly the involvement of Mst1/Sirt1 signaling.

Main Methods:

• Induction of myocardial infarction in mice models.
• Administration of melatonin post-MI.
• Echocardiography and Masson staining for cardiac function and remodeling assessment.
• Analysis of autophagy, apoptosis, and mitochondrial integrity markers.
• Utilized Mst1 transgenic and knockout mice to investigate the role of Mst1/Sirt1 signaling.

Main Results:

• Melatonin significantly alleviated cardiac dysfunction and adverse left ventricle remodeling post-MI.
• Melatonin treatment increased autophagy, reduced apoptosis, and improved mitochondrial function.
• Melatonin inhibited Mst1 phosphorylation and promoted Sirt1 expression.
• The protective effects of melatonin were abolished in Mst1 knockout mice.

Conclusions:

• Melatonin mitigates post-MI cardiac remodeling and dysfunction by upregulating autophagy, decreasing apoptosis, and modulating mitochondrial integrity.
• The Mst1/Sirt1 signaling pathway is a key downstream mediator of melatonin's cardioprotective effects in MI.